Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on the Homologous Recombination Deficiency Status in Chinese Population With Epithelial Ovarian Cancer

NCT04190667 is registered in ClinicalTrials.gov with Lei Li as lead sponsor.

NCT NCT04190667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04190667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on the Homologous Recombination Deficiency Status in Chinese Population With Epithelial Ovarian Cancer
Lead sponsor
Lei Li
Phase
Observational
Overall status
Unknown status
Start date
December 7, 2019
Completion date
December 7, 2022
Enrollment
1,300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation, brca2 mutation, chinese, epithelial ovarian cancer, homologous recombination deficiency, prognosis